Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Encoded secures $275m for Dravet syndrome gene therapy

Sep 10, 2026, 2:23 PM

Read Full Article → Encoded secures $275m for Dravet syndrome gene therapy

Encoded secures $275m for Dravet syndrome gene therapy

Translate article text

Choose a language and wait for the translated text.

Proceeds will go towards a pivotal trial of the candidate in paediatric patients.

Encoded secures $275m for Dravet syndrome gene therapy | PharmaVoice